Deep Medicine Acquisition Corp. (DMAQ)
| Market Cap | 50.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -400,232 |
| Shares Out | 4.36M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 225 |
| Open | 11.55 |
| Previous Close | 11.55 |
| Day's Range | 11.55 - 11.55 |
| 52-Week Range | 10.16 - 19.91 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About DMAQ
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. Deep Medicine Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Deep Medicine Acquisition Corp. operates as subsidiary of Bright Vision Sponsor LLC. [Read more]
Financial Performance
Financial StatementsNews
Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.
SALT LAKE CITY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- – Deep Medicine Acquisition Corp. (NASDAQ: DMAQ) (“DMAQ”), a publicly traded special purpose acquisition company, and TruGolf, Inc. ("TruGolf”), a le...
Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement
TruGolf, Inc. (“TruGolf”) will become a public company to further advance its software business and increase manufacturing and sales of its golf simulator technology in the United States and internati...
Deep Medicine Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market
New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to ...
Deep Medicine Acquisition Corp. Announces Appointment of a New Director
New York, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”) announced today the appointment of Mr. John Chiang as a member to its board of directors,...
Deep Medicine Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination
New York, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”), announced today that an aggregate of $1,265,000 has been deposited into the Company's tr...
Chijet Motor Company, Inc. has entered into a business combination agreement with Deep Medicine Acquisition Corp. to become a public company to advance its electric vehicle business and sales of gasoline vehicles in China and Southeast Asia
Business combination agreement with Deep Medicine Acquisition Corp. value s Chijet 's operating compan ies at $2.55 billion (based on 100% ownership)
Deep Medicine Acquisition Corp. Announces Upcoming Automatic Unit Separation
New York, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQU) (the “Company”) announced today that, on December 2, 2021, the Company's units will no longer trade, and...
Deep Medicine Acquisition Corp. Completes Upsized $126,500,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option
New York, NY, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQU) (the “Company”) today announced the closing of its upsized initial public offering of 12,650,000 units ...